Prevent preclinical drug development program: cgmp production of vaccines and biologicals for cancer prevention

Ended Awarded Last action

Contract number
75N91019D00026
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • N01CN8700618 Solicitation number
Last date to order 100% complete
IDV ceiling
$74,995,000.00
Award type
Multiple award
Who can order
Only the awarding agency
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
R499 Support- Professional: Other
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00005 $0
Additional Work (new agreement, FAR part 6 applies) P00004 $0
Supplemental Agreement for work within scope P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N91019D00026?

75N91019D00026 was awarded to International Aids Vaccine Initiative Inc. by National Cancer Institute (National Institutes of Health) on August 14, 2019.

How much is contract 75N91019D00026 worth?

75N91019D00026's own ceiling is $74,995,000.

Who can order from contract 75N91019D00026?

75N91019D00026 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N91019D00026 part of a contract vehicle?

Yes. 75N91019D00026 is part of PREVENT Cancer Preclinical Drug Development Program.

Was contract 75N91019D00026 competed?

The extent of competition for 75N91019D00026 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login